Smartlab Europe

News

5 Strategies To Promote Your Dental Practice In The Digital Age

In today’s digital age, it’s more important than ever for dental practices to have a strong online presence. With so many people using the internet to find and research healthcare providers, it’s crucial to make sure your practice is...

FDA Updates Recommendations To Modernize Clinical Trials

The US Food and Drug Administration has released a draft guidance on good clinical practices (GCPs) to improve the design and implementation of clinical trials. The goal is to make trials more flexible while maintaining data accuracy and participant...

AI Algorithms Unveil Abaucin To Combat Resilient Pathogen

McMaster University and Massachusetts Institute of Technology scientists leverage artificial intelligence to uncover a novel antibiotic named abaucin. This breakthrough has the potential to combat a dangerous drug-resistant bacterium, Acinetobacter baumannii, which affects vulnerable hospital patients. A. baumannii is...

Power of Immune Checkpoint Inhibitors In Cancer Treatment

Scientists at Tohoku University in Japan have made a significant discovery in the field of cancer treatment. They have found a new approach to enhance the efficacy of immune checkpoint blockade (ICB), a type of cancer therapy that uses...

Pharma Companies Support Antibiotic Waste Control Measures

BSI, a UK standards body, introduced a new certification called the Minimized Risk of Antimicrobial Resistance (AMR) to promote responsible antibiotic manufacturing in the global pharmaceutical supply chain. This certification, released in June 2022, is built upon the Antibiotic...

Antibiotic Tolerant Lung Issues Get New Singapore Therapy

Scientists from the Antimicrobial Resistance Interdisciplinary Research Group at the Singapore-MIT Alliance for Research and Technology, which happens to be MIT's research enterprise in the country, in partnership with Nanyang Technological University and also National University Hospital, have gone...

Targeted Drug Mix For Ovarian Cancer Cases Twice Effective

A targeted drug combination for patients suffering from an ovarian cancer type can be nearly twice as effective as the next-best treatment, according to preliminary results from a Phase II study. Researchers opine that these results, which happen to be...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »